Загрузка...
Imatinib may be ABL to improve anti-angiogenic therapy
We recently reported that neuropilin 1 (NRP1) drives angiogenesis by promoting extracellular matrix signaling in endothelial cells via ABL1 kinase. Imatinib targets this pathway in pathological angiogenesis and may provide a novel opportunity for anti-angiogenic therapy of age-related macular degene...
Сохранить в:
| Опубликовано в: : | Mol Cell Oncol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905228/ https://ncbi.nlm.nih.gov/pubmed/27308396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723548.2014.968034 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|